or Try an Advanced Search...

    Human Monoclonal Antibodies Stocks List

    Symbol Grade Name % Change
    ARDS F Aridis Pharmaceuticals Inc. 1.69
    REGN C Regeneron Pharmaceuticals, Inc. 1.34
    VCNX F Vaccinex, Inc. 1.12
    XOMA B XOMA Corporation -1.73
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antibodies Monoclonal Antibodies Immune System Immunology Infectious Diseases Medicine Antibody Biopharmaceutical Biotechnology Cardiovascular Disease Clinical Development Non Small Cell Lung Cancer Small Cell Lung Cancer Vascular Disease Acne Allergy Angiogenesis Antibody Product Asthma Atopic Dermatitis

    Related ETFs - A few ETFs which own one or more of the above listed Human Monoclonal Antibodies stocks.

    Symbol Grade Name Weight
    IBBQ C Invesco Nasdaq Biotechnology ETF 8.16
    IBB C iShares Nasdaq Biotechnology Index Fund 8.14
    BBH C Market Vectors Biotech ETF 7.72
    BIB C ProShares Ultra Nasdaq Biotechnology 5.92
    PJP B PowerShares Dynamic Pharmaceuticals 5.57
    View all Human Monoclonal Antibodies ETFs...
    Compare ETFs
    Compare BBH to BIB Compare BIB to PJP Compare IBBQ to BBH

        Human Monoclonal Antibodies Stocks Recent News

        Date Stock Title
        May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
        May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
        May 3 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
        May 3 REGN Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight
        May 2 REGN Regeneron Pharmaceuticals, Inc. (REGN) Q1 2024 Earnings Call Transcript
        May 2 REGN Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
        May 2 REGN Regeneron (REGN) Reports Q1 Earnings: What Key Metrics Have to Say
        May 2 REGN Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings: Challenges and Opportunities Amidst ...
        May 2 REGN Regeneron Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 2 REGN Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
        May 2 REGN Regeneron falls after Q1 miss; announces $3B share buybacks
        May 2 REGN 3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
        May 2 REGN Regeneron Earnings Miss; Biotech Giant's Stock Falls
        May 2 REGN Regeneron Pharmaceuticals misses top-line and bottom-line estimates; updates FY24 outlook
        May 2 REGN Regeneron Reports First Quarter 2024 Financial and Operating Results
        May 1 REGN Regeneron Pharmaceuticals Q1 2024 Earnings Preview
        May 1 REGN Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
        Apr 30 REGN Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
        Apr 30 REGN Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
        Apr 30 XOMA XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
        Related Industries: Biotechnology
        Related Stock Lists: Antibodies Monoclonal Antibodies Immune System Immunology Infectious Diseases Medicine Antibody Biopharmaceutical Biotechnology Cardiovascular Disease Clinical Development Non Small Cell Lung Cancer Small Cell Lung Cancer Vascular Disease Acne Allergy Angiogenesis Antibody Product Asthma Atopic Dermatitis
        Human Monoclonal Antibodies

        Human monoclonal antibodies are laboratory-produced proteins that are designed to mimic the antibodies naturally produced by the human immune system. They are created by cloning a single antibody-producing B-cell, which produces identical copies of the same antibody. These antibodies are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases.

        Browse All Tags